{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:13:43Z","timestamp":1792098823995,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603361"],"award-info":[{"award-number":["81603361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113568","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T18:03:51Z","timestamp":1730570631000},"page":"113568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P3","title":["Baricitinib inhibits the activation of innate immune cells and exerts therapeutic effects on acute peritonitis and systemic inflammatory response syndrome"],"prefix":"10.1016","volume":"143","author":[{"given":"Doudou","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanggan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.intimp.2024.113568_b0005","doi-asserted-by":"crossref","first-page":"13397","DOI":"10.3390\/ijms222413397","article-title":"Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) ligands as immunotherapeutic agents for hematopoietic diseases","volume":"22","author":"Wicherska-Pawlowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2024.113568_b0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113568_b0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","article-title":"Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-\u03baB signaling in resident macrophages","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2024.113568_b0020","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.intimp.2024.113568_b0025","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1021\/jm401490p","article-title":"Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases","volume":"57","author":"Clark","year":"2014","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2024.113568_b0030","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"issue":"7","key":"10.1016\/j.intimp.2024.113568_b0035","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","article-title":"Baricitinib versus placebo or adalimumab in rheumatoid arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.113568_b0040","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1080\/09546634.2021.1967268","article-title":"Baricitinib for the treatment of atopic dermatitis","volume":"33","author":"Melo","year":"2022","journal-title":"J. Dermatolog. Treat."},{"issue":"18","key":"10.1016\/j.intimp.2024.113568_b0045","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two phase 3 trials of baricitinib for alopecia areata","volume":"386","author":"King","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.intimp.2024.113568_b0050","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with Covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.113568_b0055","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2020.11.007","article-title":"Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques","volume":"184","author":"Hoang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.113568_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106637","article-title":"Comparison of three analytical methods for superoxide produced by activated immune cells","volume":"101","author":"Zhu","year":"2020","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.intimp.2024.113568_b0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-physiol-022516-034348","article-title":"Macrophages and the recovery from acute and chronic inflammation","volume":"79","author":"Hamidzadeh","year":"2017","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113568_b0070","first-page":"914","article-title":"Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase \u2162 randomized VOLTAIRE-RA equivalence study","volume":"77","author":"Cohen","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.113568_b0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13075-017-1371-4","article-title":"A phase \u2162, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA) to the reference product (Humira) in patients with active rheumatoid arthritis","volume":"19","author":"Jamshidi","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"14","key":"10.1016\/j.intimp.2024.113568_b0080","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1182\/blood.2021012295","article-title":"Neutrophils in acute inflammation: current concepts and translational implications","volume":"139","author":"Margraf","year":"2022","journal-title":"Blood"},{"issue":"Pt B","key":"10.1016\/j.intimp.2024.113568_b0085","article-title":"Ibrutinib suppresses the activation of neutrophils and macrophages and exerts therapeutic effect on acute peritonitis induced by zymosan","volume":"113","author":"Guo","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113568_b0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1182\/blood-2007-07-099648","article-title":"The coordinated action of G-CSF and ELR+ CXC chemokines in neutrophil mobilization during acute inflammation","volume":"111","author":"Wengner","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.113568_b0095","article-title":"Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113568_b0100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ndt\/gfr302","article-title":"Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model","volume":"27","author":"Kato","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"16","key":"10.1016\/j.intimp.2024.113568_b0105","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1111\/bph.15847","article-title":"Synergistic effects of two naturally occurring iridoids in eliciting a rapid antidepressant action by up-regulating hippocampal PACAP signaling","volume":"179","author":"Zhang","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113568_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107808","article-title":"Andrographolide ameliorates neuroinflammation in APP\/PS1 transgenic mice","volume":"96","author":"Zhang","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"7485","key":"10.1016\/j.intimp.2024.113568_b0115","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nature12862","article-title":"Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity","volume":"505","author":"Schoggins","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.intimp.2024.113568_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/v14102180","article-title":"Pin-pointing the key hubs in the IFN-\u03b3 pathway responding to SARS-CoV-2 infection","volume":"14","author":"Toro","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.intimp.2024.113568_b0125","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1189\/jlb.69.4.598","article-title":"Requirement for STAT1 in LPS-induced gene expression in macrophages","volume":"69","author":"Ohmori","year":"2001","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113568_b0130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/tox.22935","article-title":"S1P facilitates IL-1\u03b2 production in osteoblasts via the JAK and STAT3 signaling pathways","volume":"35","author":"Hu","year":"2020","journal-title":"Environ. Toxicol."},{"issue":"14","key":"10.1016\/j.intimp.2024.113568_b0135","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.113568_b0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cyto.2013.04.027","article-title":"Selective JAK\/STAT3 signalling regulates transcription of colony stimulating factor-2 and -3 in Concanavalin-A-activated mesenchymal stromal cells","volume":"63","author":"Zgheib","year":"2013","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.intimp.2024.113568_b0145","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1128\/IAI.00856-15","article-title":"Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages","volume":"83","author":"Finethy","year":"2015","journal-title":"Infect. Immun."},{"issue":"23","key":"10.1016\/j.intimp.2024.113568_b0150","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.1074\/jbc.RA120.013544","article-title":"Guanylate-binding protein 2 orchestrates innate immune responses against murine norovirus and is antagonized by the viral protein NS7","volume":"295","author":"Yu","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2024.113568_b0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1753425913484374","article-title":"Caspase-1: the inflammasome and beyond","volume":"20","author":"Sollberger","year":"2014","journal-title":"Innate Immu."},{"issue":"2","key":"10.1016\/j.intimp.2024.113568_b0160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/00220345211024528","article-title":"CBD promotes oral ulcer healing via inhibiting CMPK2-mediated inflammasome","volume":"101","author":"Qi","year":"2022","journal-title":"J. Dent. Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.113568_b0165","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1152\/ajpendo.00347.2013","article-title":"NF-\u03baB and STAT1 control CXCL1 and CXCL2 gene transcription","volume":"306","author":"Burke","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.intimp.2024.113568_b0170","first-page":"527","article-title":"Tangeretin inhibits IL-12 expression and NF-\u03baB activation in dendritic cells and attenuates colitis in mice","volume":"83","author":"Eun","year":"2017","journal-title":"Planta Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.113568_b0175","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1096\/fj.10-170597","article-title":"Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability","volume":"25","author":"Strebovsky","year":"2011","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.intimp.2024.113568_b0180","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10753-016-0374-7","article-title":"Geraniin inhibits LPS-induced THP-1 macrophages switching to M1 phenotype via SOCS1\/NF-\u03baB pathway","volume":"39","author":"Liu","year":"2016","journal-title":"Inflammation"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924020903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924020903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:23:52Z","timestamp":1733959432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924020903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":36,"alternative-id":["S1567576924020903"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113568","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baricitinib inhibits the activation of innate immune cells and exerts therapeutic effects on acute peritonitis and systemic inflammatory response syndrome","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113568"}}